Vinorelbine and Gemcitabine Versus Capecitabine in Pretreated Metastatic Breast Cancer
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
The combination of vinorelbine and gemcitabine seems to be an important part of the
chemotherapy regimens used in metastatic breast cancer patients following treatment failure
with the combination of a taxane and an anthracycline. Capecitabine rescue monotherapy in
metastatic breast cancer patients following treatment failure with the combination of a
taxane and an anthracycline, also seems to be an important part of the chemotherapy regimens
used in metastatic breast cancer patients. Whether the combination of vinorelbine and
gemcitabine or capecitabine administration is preferable is not yet known, especially in
patients with metastatic disease.